Those most eager to sacrifice drug-rebate reforms might be the White House staffers who control the release of the rule to ban rebates in Medicare and Medicaid managed care that are not shared at the pharmacy counter, according to an investment firm that recently spoke with White House officials. “[W]hile the White House is keen on the Safe Harbor rule, in our view per our conversations with Joe Grogan and John O'Brien, the Administration would prefer bipartisan legislation and it...